Twenty years have passed since the first studies using human papillomavirus (HPV) testing
began in clinical settings. At that time controversy regarding the role of HPV in cervical …

Human papillomavirus (HPV) infection is a necessary cause of cervical cancer; HPV testing
capitalizes on this fact to maximize the clinical benefits of cervical screening and abnormal …

Current cervical cancer screening programs are changing due to the development of tests
that detect the presence of human papillomavirus (HPV), the cause of cervical cancer. These …

Cervical cancer is a largely preventable disease through the detection, treatment and follow-
up of its precursors. Traditionally, this has been accomplished through screening women …

Cervical cancer is a major cause of death, and the second most frequent cancer in women
worldwide. Many studies have indicated a causal relation between genital human …

Cervical cancer continues to be a major epidemiologic problem in developed and
underdeveloped nations alike. Current screening practices rely on cervical cytology for the …

Despite its history of success in cancer screening, Pap cytology has important limitations,
particularly its high false-negative rate, which carries important public health implications …

Cervical cancer is an infectious disease and it is now well established that oncogenic, or
high-risk, HPVs (HR-HPV) are the main and necessary causal factor in the development of …

The discovery of the necessary cause of cervical cancer, human papillomavirus (HPV), has
led to important technological advances, including the development of molecular tests for …

Recent decades have witnessed a reduction in the incidence of cervical cancer in countries
where screening programmes have achieved broad coverage. The recognized importance …